Filing Details
- Accession Number:
- 0001104659-16-101835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-02 16:20:29
- Reporting Period:
- 2016-02-29
- Filing Date:
- 2016-03-02
- Accepted Time:
- 2016-03-02 16:20:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1628214 | Lisa Alderson | C/O Invitae Corporation 458 Brannan Street San Francisco CA 94107 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-29 | 5,000 | $3.42 | 29,319 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-02-29 | 5,000 | $9.05 | 24,319 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-02-29 | 5,000 | $0.00 | 5,000 | $3.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,833 | 2017-12-31 | No | 4 | M | Direct |
Footnotes
- Represents a weighted average sale price. Actual sales prices ranged from $9.03 to $9.05.
- Reporting person undertakes to provide upon request to the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- The option became exercisable as to 25% of the shares on February 28, 2015, and becomes exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
